DHQZ-17 (Compound 17) is a Hepatocyte nuclear factor 4 alpha (HNF4A) inhibitor. DHQZ-17 has potent anticancer activity against human head and neck squamous cells (SCC131 cells) and with no toxicity to normal cells. DHQZ-17 significantly inhibits SCC131 cells growth with an IC50 of 1.75 µM, and induces apoptosis and G2/M cell cycle arrest. DHQZ-17 promotes tumor regression in SCC131 tumor xenografts mouse models[1].
Molekulargewicht:
358.31
CAS Nummer:
[2408759-14-6]
Formel:
C19H13F3N2O2
Target-Kategorie:
Apoptosis,Orphan Nuclear Receptor
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
